Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vidya Mave

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Plos One|July 30, 2020
Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in IndiaMandar Paradkar, Chandrasekaran Padmapriyadarsini, Divyashri Jain, et al.
The Lancet. HIV|August 3, 2019
Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy studyBeatriz Grinsztejn, Michael D Hughes, Justin Ritz, et al.
The New England Journal of Medicine|March 9, 2022
Shorter Treatment for Nonsevere Tuberculosis in African and Indian ChildrenAnna Turkova, Genevieve H Wills, Eric Wobudeya, et al.
The Lancet. HIV|October 14, 2022
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panelMaurine D Miner, Mark Hatherill, Vidya Mave, et al.
Journal of the International AIDS Society|August 30, 2022
Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trialAnchalee Avihingsanon, Michael D Hughes, Robert Salata, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Novel Genetic Locus Associated with Resistance to <i>M. tuberculosis</i> Infection: A Multi-Ancestry Genome-Wide Association StudyNeel R Gandhi, Matheus Fernandes Gyorfy, Mandar Paradkar, et al.
Plos Medicine|September 12, 2019
Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysisOmowunmi Aibana, Chuan-Chin Huang, Said Aboud, et al.
The European Respiratory Journal|November 3, 2022
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysisFajri Gafar, Roeland E Wasmann, Helen M McIlleron, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Plos One|July 30, 2020
Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in IndiaMandar Paradkar, Chandrasekaran Padmapriyadarsini, Divyashri Jain, et al.
The Lancet. HIV|August 3, 2019
Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy studyBeatriz Grinsztejn, Michael D Hughes, Justin Ritz, et al.
The New England Journal of Medicine|March 9, 2022
Shorter Treatment for Nonsevere Tuberculosis in African and Indian ChildrenAnna Turkova, Genevieve H Wills, Eric Wobudeya, et al.
The Lancet. HIV|October 14, 2022
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panelMaurine D Miner, Mark Hatherill, Vidya Mave, et al.
Journal of the International AIDS Society|August 30, 2022
Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trialAnchalee Avihingsanon, Michael D Hughes, Robert Salata, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Novel Genetic Locus Associated with Resistance to <i>M. tuberculosis</i> Infection: A Multi-Ancestry Genome-Wide Association StudyNeel R Gandhi, Matheus Fernandes Gyorfy, Mandar Paradkar, et al.
Plos Medicine|September 12, 2019
Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysisOmowunmi Aibana, Chuan-Chin Huang, Said Aboud, et al.
The European Respiratory Journal|November 3, 2022
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysisFajri Gafar, Roeland E Wasmann, Helen M McIlleron, et al.
Pageof 15